Acutaas Chemicals (ACUTAAS) AI Stock Analysis

Acutaas Chemicals

(NSE:ACUTAAS)

Select Model

Rating:72Outperform

Price Target:INR 4,420.00▲(13.55% Upside)

Action:reiterated

Date:10/30/26

The score is driven primarily by strong financial performance (rapid FY2026 growth, sharply improved margins, and low leverage) and supportive technical momentum (price well above major moving averages with positive MACD). Offsetting these positives, valuation is stretched (high P/E and low dividend yield) and cash-flow quality remains a key risk due to consistently negative free cash flow and historical operating cash flow volatility.

Positive Factors

Revenue and Profitability GrowthThe sharp FY2026 acceleration in revenue and profitability indicates stronger earnings capacity and potential operating leverage. If maintained, this improvement can support reinvestment, strengthen the company’s competitive position, and provide a larger base for future growth over the next several quarters.

Negative Factors

Persistently Negative Free Cash FlowNegative free cash flow across the reported period means accounting profits have not translated into surplus cash after investment or working-capital needs. If persistent, this can constrain internally funded expansion, increase reliance on financing, and reduce flexibility during weaker operating periods.

Acutaas Chemicals (ACUTAAS) vs. iShares MSCI India ETF (INDA)

Market Cap: INR 327.78B
Dividend Yield: 0.06%
Average Volume (3M): 34.23K
Price to Earnings (P/E): 74.6
Beta (1Y): 1.42
Revenue Growth: 45.18%
EPS Growth: 96.07%
Country: India
Employees: 1,007
Sector: General
Sector Strength: 55
Industry: Chemicals - Specialty

Acutaas Chemicals Business Overview & Revenue Model

Company Description

Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceu...

Acutaas Chemicals Financial Statement Overview

Summary

Strong FY2026 inflection with ~52% revenue growth and materially higher profitability (net margin ~26.6%, EBIT margin ~33.2%), supported by very low recent leverage (debt-to-equity ~0.01–0.02) and improved ROE (~21.5%). Score is tempered by weak cash quality: free cash flow has been negative in all years shown and operating cash flow has been volatile (including a negative year), despite improvement in FY2026.

Income Statement

86Very Positive

Balance Sheet

88Very Positive

Cash Flow

54Neutral

Financial statement breakdown
Breakdown	TTM	Mar 2025	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	10.97B	10.07B	6.17B	5.18B	3.41B	2.40B
Gross Profit	5.17B	4.55B	2.86B	1.94B	1.22B	776.58M
EBITDA	3.02B	2.32B	1.27B	1.08B	811.14M	438.14M
Net Income	2.24B	1.59B	832.90M	719.46M	539.99M	274.70M
Balance Sheet
Total Assets	16.96B	15.49B	7.67B	6.59B	4.13B	2.32B
Cash, Cash Equivalents and Short-Term Investments	2.41B	2.49B	586.70M	615.46M	26.85M	38.22M
Total Debt	83.49M	129.39M	36.00M	8.44M	1.37B	594.20M
Total Liabilities	2.57B	2.29B	1.73B	1.37B	2.46B	1.20B
Stockholders Equity	14.14B	13.10B	5.94B	5.22B	1.67B	1.12B
Cash Flow
Free Cash Flow	-46.49M	-763.00M	-308.73M	-424.18M	-794.33M	54.71M
Operating Cash Flow	1.37B	1.18B	655.30M	-86.60M	271.45M	270.77M
Investing Cash Flow	-1.40B	-2.24B	-330.44M	-1.24B	-1.00B	-239.44M
Financing Cash Flow	-91.38M	2.61B	-122.50M	1.40B	721.08M	1.94M

Acutaas Chemicals Technical Analysis

Technical Analysis SentimentPositive

Last Price3892.60

Price Trends

50DMA3281.69Positive

100DMA3309.73Positive

200DMA2816.39Positive

Market Momentum

MACD149.83Negative

RSI72.72Negative

STOCH87.12Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ACUTAAS, the sentiment is Positive. The current price of 3892.60 is above the 20-day moving average (MA) of 3314.08, above the 50-day MA of 3281.69, and above the 200-day MA of 2816.39, indicating a bullish trend. The MACD of 149.83 indicates Negative momentum. The RSI at 72.72 is Negative, neither overbought nor oversold. The STOCH value of 87.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:ACUTAAS.

Acutaas Chemicals Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IN:ACUTAAS against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IN:ACUTAAS	72Outperform	INR 327.70B	74.64	―	0.06%	45.18%	96.07%
IN:VINATIORGA	70Outperform	INR 102.97B	22.93	―	0.86%	10.98%	-5.48%
IN:ATUL	68Neutral	INR 147.89B	19.18	―	0.60%	18.15%	42.38%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%
IN:AETHER	55Neutral	INR 215.08B	90.95	―	―	30.76%	28.12%
IN:ANURAS	49Neutral	INR 129.99B	74.35	―	0.13%	51.77%	36.90%
IN:AARTIIND	47Neutral	INR 157.96B	29.74	―	0.23%	39.85%	103.71%

* General Sector Average

Performance Comparison

IN:ACUTAAS and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IN:ACUTAAS	Acutaas Chemicals Ltd	4002.65	2172.87	118.75%
IN:AARTIIND	AARTI Industries Ltd	435.45	50.76	13.20%
IN:AETHER	Aether Industries Ltd.	1620.45	863.60	114.10%
IN:ANURAS	Anupam Rasayan India Ltd.	1141.80	69.42	6.47%
IN:ATUL	Atul Limited	5023.05	-838.81	-14.31%
IN:VINATIORGA	Vinati Organics Limited	993.30	-654.08	-39.70%

Acutaas Chemicals Corporate Events

Acutaas Chemicals Publishes Q2 and Half-Year 2026 Investor Presentation

Oct 27, 2026

Acutaas Chemicals Limited has released an investor presentation detailing its financial results for the second quarter and half year ended September 30, 2026, along with updates on other business matters. The presentation, published in compliance wit...

Acutaas Chemicals Sets Record Date for 50% Final Dividend

Aug 29, 2026

Acutaas Chemicals Limited has set 17 September 2026 as the record date to determine shareholders eligible to receive a proposed final dividend for the financial year 2025-26. The company plans a payout of Rs. 2.50 per fully paid equity share of face...

Acutaas Chemicals Outlines TDS Rules on Proposed FY26 Final Dividend

Aug 29, 2026

Acutaas Chemicals has informed shareholders that its board has recommended a final dividend of Rs 2.50 per equity share with a face value of Re 5 for FY 2025-26, subject to approval at the 19th Annual General Meeting on 24 September 2026. The dividen...

Acutaas opens South Korean semiconductor materials plant via Indichem

Aug 28, 2026

Acutaas Chemicals has inaugurated a semiconductor materials plant in Gongju, South Korea, via its step-down subsidiary Indichem Inc., completing the state-of-the-art facility just eleven months after groundbreaking. The plant sits on a 16,513.7 sq. m...

Acutaas Chemicals Publishes AGM Notice to Meet SEBI Disclosure Rules

Aug 24, 2026

Acutaas Chemicals Limited has notified exchanges that it has published newspaper advertisements regarding its 19th Annual General Meeting, scheduled for September 24, 2026 at 11:30 a.m. IST. The notices appeared in the Financial Express All India Eng...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 30, 2026

Acutaas Chemicals AI Stock Analysis